Article
Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases
5 Aug 2020
Abstract excerpt
The role of Discoidin Domain Receptors (DDRs) is poorly understood in neurodegeneration. DDRs are upregulated in Alzheimer's and Parkinson's disease (PD), and DDRs knockdown reduces neurotoxic protein levels. Here we show that potent and preferential DDR1 inhibitors reduce neurotoxic protein levels in vitro and in vivo. Partial or complete deletion or inhibition of DDR1 in a mouse model challenged with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
